For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Found in the inbox: Letter from specialists supporting general practice
+News
Found in the inbox: Letter from specialists supporting general practice
Monday 29 June 2020, 04:31 PM

Oops – lost in the email
Back on 23 April, I received an email from Wellington general physician Marion Leighton on behalf of a group of specialists in support of GPs and general practice. I can only think it was overlooked amidst the craziness that was publishing in lockdown, and I apologise greatly because I know the sentiments in the letter would have been warmly received by many GPs at the time. I’m publishing it now so the support expressed by the specialists joins the historical record of life under COVID-19 – Barbara Fountain, editor
23 April 2020
Editor,
I would like to draw your attention to the following statement that I and a group of my specialist colleagues have written
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.